HIV Hybrid Medical Science Liaison

Job Family: Medical & Regulatory Affairs Compensation: USD 185000 - USD 220000 - yearly Job Summary The role of the Theratechnologies Hybrid Medical Science Liaison (MSL) is pivotal, embodying a specialized, field‑oriented expertise in the realm of HIV therapeutics, through support of ibalizumab, tesamorelin and crofelemer. Adhering rigorously to regulatory and corporate directives, the MSL will adeptly foster and nurture scientific partnerships within the relevant scientific communities. This critical role entails engaging with designated Key Opinion Leaders (KOLs) and healthcare practitioners (HCPs) at national, regional, and local levels. Reporting to the EVERSANA National Director‑Head of Field Medical for Thera/FuturePak, the Hybrid Medical Science Liaison (hMSL) is a Medical Affairs professional that will serve as an external scientific representative of Theratechnologies engaging with Key Opinion Leaders (KOLs) and Healthcare Professionals (HCPs). The hMSL will develop and maintain proactive relationships with designated KOLs and assigned institutions to provide compliant, proactive scientific education for in‑line products, in person and virtually in full alignment with Medical Affairs strategies and tactics. The hMSL will provide reactive responses to unsolicited requests for medical information from medical professionals on an ad‑hoc basis and in compliance with corporate policies and procedures, and U.S. healthcare laws and regulations. The hMSL will collaborate with peers to ensure timely fulfillment of these requests during all business hours. Responsibilities Contribute to the development and maintenance of long‑term collaborative relationships with Key Opinion Leaders (KOLs) using specific engagement topics with KOLs and HCPs, in alignment with Medical Affairs strategies and tactics. Provide proactive scientific engagement with clearly identified and documented KOLs in support of existing products and delivery of disease‑state education. Respond to documented unsolicited requests for medical/scientific information on company products, including unsolicited requests for off‑label medical information, as per corporate policies and procedures, and U.S. healthcare laws and regulations. Foster productive professional relationships and partnerships with KOLs and HCPs in the areas of medical education and research, in alignment with National Field Medical strategy. Work with other team members to provide rapid responses to unsolicited requests for medical information during business hours in compliance with corporate policies and procedures and U.S. healthcare laws and regulations. Identify and communicate medical/scientific insights and trends that are relevant to Theratechnologies and its stakeholders (e.g., the competitive landscape, unmet needs of investigators, researchers, physicians). Document field‑generated scientific insights within appropriate system(s), within 48 hours and communicated to appropriate internal stakeholders, as required. Support medical leadership in execution of aligned field strategy. Contribute to the development of medical affairs materials, such as slide decks, publications, internal communications, etc., as needed. Represent Theratechnologies at medical and scientific conferences. Provide appropriate scientific insights and summaries to internal stakeholders. Support the development of scientific resources following congress/conference, as requested. Provide virtual updates on key medical congresses and collect, analyze, and summarize the impact of relevant data and competitive information on behalf of the MSL team. Maintain clinical, scientific, and technical expertise through continuous learning and knowledge of scientific literature. This includes up‑to‑date knowledge of current and emerging therapies in the HIV therapeutic space, including clinical information and competitive product information, in order to confidently speak with internal and external partners. Effectively deliver medical and scientific presentations to broad audiences, including physicians, nurses, and other clinic staff, as needed, to support scientific share of voice. Identify and communicate opportunities to partner with KOLs on disease‑state and/or therapeutic‑area initiatives. Adhere to corporate SOPs and ensure vigilant compliance with relevant legal and regulatory guidelines governing scientific interactions with physicians and healthcare professionals across all activities, including those related to clinical trials, scientific interactions with internal and external groups, and responses to unsolicited requests for medical/scientific information. Willingness to contribute to the achievement of organizational goals beyond the borders of a geographic territory. Ability to travel up to 40% of the time to participate, as needed for congress coverage, scientific support, and field‑based team educational activities. Qualifications Requirements, Critical Skills, and Experience A graduate degree and relevant clinical / pharmaceutical experience is required. BSc. from an accredited institution required, and in addition fulfill one of the following education levels and experience criteria: Advanced science / clinical degree (PharmD, M.D., DO, Ph.D., MSN, PA‑C) with one or more (1+) years of relevant clinical or therapeutic experience or Master’s degree in health sciences (e.g., MS, MSN, MPH, MHA) with three or more (3+) years of relevant clinical or therapeutic area experience. Combined BSc. with an MBA, or BSN with a MBA, and five or more (5+) years of relevant clinical or therapeutic area experience. Communication skills which display comfort, agility, and confidence in a variety of situations. Learns quickly and adapts rapidly in complex and/or stressful situations, with ability to manage multiple and shifting priorities. Challenges the status quo by asking appropriate questions and offering alternative solutions. Creates a learning environment and is open to suggestions and experimentation for improvement. Embraces the ideas of others, nurtures innovation, and manages innovation to reality. Ability to use field‑based electronic or other communication tools for all aspects of job. Requires a deep understanding of scientific, clinical, market and product information and the ability to discuss and communicate this information with top experts in their field. Requires the knowledge and expertise to interpret expert insights and share this information with internal stakeholders across multiple functions. Demonstrate high ethical and professional standards with all business contacts. Embodies a can‑do mindset with a willingness to support key company initiatives. Builds strong relationships with peers and cross‑functionally with partners outside of team and/or organization to enable higher performance. Demonstrates a positive, enthusiastic attitude. Able to accommodate up to 40% travel. Senior hMSLs will have at least 4 years of MSL experience and will demonstrate a high degree of familiarity with regulatory guidelines and industry standards related to scientific medical engagement and scientific engagement. hMSLs will be equipped with 0–3 years’ experience in pharma/biotech or relevant clinical/practice/research background with strong communication skills and high learning agility who express professional presence with KOLs despite limited experience. Consistent with the Americans with Disabilities Act (ADA) and applicable state and local laws, it is the policy of EVERSANA to provide reasonable accommodation when requested by a qualified applicant or candidate with a disability, unless such accommodation would cause an undue hardship for EVERSANA. The policy regarding requests for reasonable accommodations applies to all aspects of the hiring process. If reasonable accommodation is needed to participate in the interview and hiring process, please contact us at [email protected] . We are an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, disability, veteran status or any other protected classification. #J-18808-Ljbffr EVERSANA Life Sciences LLC